Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_assertion type Assertion NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_head.
- NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_assertion description "[RT-PCR analysis demonstrated that TRP-2 was present in 51.2% of primary tumor cell lines derived from patients with glioblastoma multiforme (GBM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_provenance.
- NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_assertion evidence source_evidence_literature NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_provenance.
- NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_assertion SIO_000772 12843792 NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_provenance.
- NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_assertion wasDerivedFrom befree-20140225 NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_provenance.
- NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_assertion wasGeneratedBy ECO_0000203 NP380205.RAQ6poR3Tb2LT1ocKcvmIA8_SyVpFdExju2fjzdK3Y9W8130_provenance.